For those that haven't seen this. Ritu Baral at Canacord. Quarterly sales up 10% over previous quarter. December up 3% over November. This quarter should be much better by comparison. Last quarter had hurricane and seasonal factors.
Good Luck to all longs
AVNR - $3.13| BUY | $6 PT | Market Cap $428M | Ritu Baral
The Nuedexta launch relentlessly continues to make gains in prescription numbers. As marketing continues to ramp with the launch of DTC campaigns, increased number of targeted LTC beds, and a shifting focus on the retail front, we expect continued steady growth in prescriptions.
Monthly IMS update: Nuedexta December TRx's up 3% over November; Q4/12 TRx up 10% over Q3/12